Donor funding has fuelled a vast increase in service delivery, medical research and clinical trials throughout the developing world. Yet, there is a dark side to this badly needed influx of funding: with pressures to spend funds quickly and achieve results, projects may not pay sufficient attention to internal monitoring and security systems to protect against embezzlement. This U4 Brief analyses how this type of corruption occurred in a donor-funded project, and what can be done to minimise the risk.
Good governance for medicines initiatives: Exploring lessons learned
Jillian Clare Kohler, Natalia Ovtcharenko
Traiter le problème de la corruption dans le secteur de la santé: Comment assurer un accès équitable pour tous aux soins de santé
150 million euros confiscated following vice-president Obiang’s conviction in France
Addressing the “seven deadly thins” — weak spots where corruption can fester